The Bioactivity of Pomegranate: Impact on Health and Disease

被引:156
作者
Faria, Ana [1 ,2 ]
Calhau, Conceicao [1 ]
机构
[1] Univ Porto, Biochem Dept FCT U38, Fac Med, P-4200319 Oporto, Portugal
[2] Univ Porto, Dept Chem, Fac Sci, Chem Invest Ctr CIQ, P-4169007 Oporto, Portugal
关键词
antioxidant; cancer; ellagitannin; inflammation; pomegranate; punicalagin; PUNICA-GRANATUM POMEGRANATE; CYTOCHROME-P450 3A CYP3A; HUMAN BREAST-CANCER; ST-JOHNS-WORT; ANTIOXIDANT ACTIVITY; FRUIT EXTRACT; IN-VITRO; SEED OIL; JUICE CONSUMPTION; OXIDATIVE STRESS;
D O I
10.1080/10408391003748100
中图分类号
TS2 [食品工业];
学科分类号
100403 [营养与食品卫生学];
摘要
The aim of the present review is to discuss the cumulative evidence that suggests that pomegranate consumption possesses a diverse array of biological actions and may be helpful in the prevention of some inflammatory-mediated diseases including cancer. The pomegranate fruit can be divided into at least three parts-seeds, peel, and juice. All these components have been studied for their antioxidant properties in a chemoprevention approach. Pomegranate exerts antiproliferative, anti-invasive, and antimetastatic effects, induces apoptosis through modulation of Bcl-2 proteins, increases p21 and p27, and downregulates cyclin-cdk network. In addition, pomegranate inhibits the activation of inflammatory pathways including, but not limited to, the NF kappa-B pathway. Anti-cancer effects with the most impressive data have been demonstrated so far in prostate cancer.
引用
收藏
页码:626 / 634
页数:9
相关论文
共 95 条
[81]
Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro [J].
Shukla, Meenakshi ;
Gupta, Kalpana ;
Rasheed, Zafar ;
Khan, Khursheed A. ;
Haqqi, Tariq M. .
JOURNAL OF INFLAMMATION-LONDON, 2008, 5 (1)
[82]
Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells [J].
Shukla, S ;
Gupta, S .
MOLECULAR CARCINOGENESIS, 2004, 39 (02) :114-124
[83]
Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models [J].
Singh, RP ;
Murthy, KNC ;
Jayaprakasha, GK .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2002, 50 (01) :81-86
[84]
Herbal remedies in the United States: Potential adverse interactions with anticancer agents [J].
Sparreboom, A ;
Cox, MC ;
Acharya, MR ;
Figg, WD .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2489-2503
[85]
Reactive oxygen species in tumor progression [J].
Storz, P .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :1881-1896
[86]
Pomegranate derived products for cancer chemoprevention [J].
Syed, Deeba N. ;
Afaq, Farrukh ;
Mukhtar, Hasan .
SEMINARS IN CANCER BIOLOGY, 2007, 17 (05) :377-385
[87]
Polyphenols:: do they play a role in the prevention of human pathologies? [J].
Tapiero, H ;
Tew, KD ;
Ba, GN ;
Mathé, G .
BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (04) :200-207
[88]
Oxidative stress, accumulation of biological 'garbage', and aging [J].
Terman, A ;
Brunk, UT .
ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (1-2) :197-204
[89]
Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo [J].
Masakazu Toi ;
Hiroko Bando ;
Cheppail Ramachandran ;
Steven J. Melnick ;
Atsushi Imai ;
Rose S. Fife ;
Raymond Eric Carr ;
Tsutomu Oikawa ;
Ephraim Philip Lansky .
Angiogenesis, 2003, 6 (2) :121-128
[90]
Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats [J].
Toklu, Hale Z. ;
Dumlu, Melek U. ;
Sehirli, Oezer ;
Ercan, Feriha ;
Gedik, Nursal ;
Goekmen, Vural ;
Sener, Goksel .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (09) :1287-1295